413 related articles for article (PubMed ID: 30144842)
1. New Biomarkers to Evaluate Hyperandrogenemic Women and Hypogonadal Men.
Karakas SE; Surampudi P
Adv Clin Chem; 2018; 86():71-125. PubMed ID: 30144842
[TBL] [Abstract][Full Text] [Related]
2. Anti-müllerian hormone and sertoli cell function in paediatric male hypogonadism.
Grinspon RP; Rey RA
Horm Res Paediatr; 2010; 73(2):81-92. PubMed ID: 20190544
[TBL] [Abstract][Full Text] [Related]
3. Clinical usefulness of low-dose oral contraceptives for the treatment of adolescent hyperandrogenemia.
Yamamoto T; Okada H
Asia Oceania J Obstet Gynaecol; 1994 Sep; 20(3):225-30. PubMed ID: 7811185
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of 'obesity-associated gonadal dysfunction' in severely obese men and women and its resolution after bariatric surgery: a systematic review and meta-analysis.
Escobar-Morreale HF; Santacruz E; Luque-Ramírez M; Botella Carretero JI
Hum Reprod Update; 2017 Jul; 23(4):390-408. PubMed ID: 28486593
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome.
Hahn S; Kuehnel W; Tan S; Kramer K; Schmidt M; Roesler S; Kimmig R; Mann K; Janssen OE
Clin Chem Lab Med; 2007; 45(2):202-7. PubMed ID: 17311509
[TBL] [Abstract][Full Text] [Related]
6. Chronic hyperandrogenemia in the presence and absence of a western-style diet impairs ovarian and uterine structure/function in young adult rhesus monkeys.
Bishop CV; Mishler EC; Takahashi DL; Reiter TE; Bond KR; True CA; Slayden OD; Stouffer RL
Hum Reprod; 2018 Jan; 33(1):128-139. PubMed ID: 29190387
[TBL] [Abstract][Full Text] [Related]
7. [Correlations between clinical signs and hormonal parameters in young women with hirsutism].
Kristesashvili J; Chanukvadze D
Georgian Med News; 2011 Nov; 11(200):30-5. PubMed ID: 22201077
[TBL] [Abstract][Full Text] [Related]
8. Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome.
Bradbury RA; Lee P; Smith HC
Aust N Z J Obstet Gynaecol; 2017 Oct; 57(5):552-557. PubMed ID: 28597496
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of different diagnostic methods for assessment of hyperandrogenism in young women with hirsutism.
Chanukvadze D; Kristesashvili J
Georgian Med News; 2011 Nov; 11(200):25-9. PubMed ID: 22201076
[TBL] [Abstract][Full Text] [Related]
10. Hirsutism and virilism in women.
Kirschner MA
Spec Top Endocrinol Metab; 1984; 6():55-93. PubMed ID: 6084314
[TBL] [Abstract][Full Text] [Related]
11. Clinical and laboratoristic strategy in late onset hypogonadism.
Lombardo F; Lupini C; Meola A; Pallotti F; Gandini L; Lenzi A
Acta Biomed; 2010; 81 Suppl 1():85-8. PubMed ID: 20518196
[TBL] [Abstract][Full Text] [Related]
12. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
Dewailly D; Pigny P; Soudan B; Catteau-Jonard S; Decanter C; Poncelet E; Duhamel A
J Clin Endocrinol Metab; 2010 Sep; 95(9):4399-405. PubMed ID: 20610596
[TBL] [Abstract][Full Text] [Related]
13. A study of the endocrine manifestations of hepatic cirrhosis.
Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
15. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
[TBL] [Abstract][Full Text] [Related]
16. New perspectives in the diagnosis of pediatric male hypogonadism: the importance of AMH as a Sertoli cell marker.
Grinspon RP; Rey RA
Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):512-9. PubMed ID: 22218431
[TBL] [Abstract][Full Text] [Related]
17. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
Cassar S; Teede HJ; Moran LJ; Joham AE; Harrison CL; Strauss BJ; Stepto NK
Clin Endocrinol (Oxf); 2014 Dec; 81(6):899-906. PubMed ID: 25040369
[TBL] [Abstract][Full Text] [Related]
18. Studies of the pituitary-Leydig cell axis in young men with hypogonadotropic hypogonadism and hyposmia: comparison with normal men, prepuberal boys, and hypopituitary patients.
Bardin CW; Ross GT; Rifkind AB; Cargille CM; Lipsett MB
J Clin Invest; 1969 Nov; 48(11):2046-56. PubMed ID: 4390462
[TBL] [Abstract][Full Text] [Related]
19. Late-onset hypogonadism in the aging male (LOH): definition, diagnostic and clinical aspects.
Schubert M; Jockenhövel F
J Endocrinol Invest; 2005; 28(3 Suppl):23-7. PubMed ID: 16042356
[TBL] [Abstract][Full Text] [Related]
20. Androgen therapy in the aging male.
Lunenfeld B
World J Urol; 2003 Nov; 21(5):292-305. PubMed ID: 14576959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]